Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
4.86
USD
-3.57%
Market Cap:
$35m
Balance Sheet
Balance Sheet Decomposition
Atara Biotherapeutics Inc
Atara Biotherapeutics Inc
Balance Sheet Decomposition is not available for
Atara Biotherapeutics Inc
Atara Biotherapeutics Inc
Balance Sheet
Atara Biotherapeutics Inc
Atara Biotherapeutics Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
4
|
52
|
22
|
24
|
48
|
79
|
61
|
74
|
200
|
106
|
93
|
26
|
25
|
|
| Cash Equivalents |
4
|
52
|
22
|
24
|
48
|
79
|
61
|
74
|
200
|
106
|
93
|
26
|
25
|
|
| Short-Term Investments |
0
|
0
|
82
|
297
|
208
|
87
|
249
|
185
|
300
|
265
|
150
|
26
|
17
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
40
|
34
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
40
|
34
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
10
|
11
|
|
| Other Current Assets |
0
|
0
|
2
|
4
|
5
|
6
|
12
|
14
|
21
|
13
|
10
|
6
|
10
|
|
| Total Current Assets |
4
|
52
|
106
|
325
|
261
|
172
|
322
|
273
|
523
|
385
|
295
|
102
|
65
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
3
|
44
|
69
|
68
|
63
|
80
|
74
|
59
|
41
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
3
|
44
|
69
|
68
|
63
|
80
|
74
|
59
|
41
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
5
|
12
|
20
|
29
|
12
|
16
|
17
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
4
|
7
|
5
|
3
|
|
| Total Assets |
4
N/A
|
52
+1 105%
|
106
+105%
|
325
+206%
|
264
-19%
|
218
-17%
|
392
+80%
|
343
-12%
|
588
+72%
|
468
-20%
|
376
-20%
|
166
-56%
|
109
-34%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
1
|
0
|
1
|
3
|
15
|
4
|
8
|
7
|
17
|
7
|
4
|
4
|
|
| Accrued Liabilities |
0
|
0
|
1
|
8
|
6
|
10
|
30
|
29
|
42
|
48
|
63
|
60
|
34
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Current Liabilities |
1
|
1
|
1
|
1
|
1
|
3
|
6
|
0
|
34
|
41
|
8
|
78
|
95
|
|
| Total Current Liabilities |
1
|
2
|
3
|
10
|
10
|
28
|
40
|
37
|
83
|
106
|
79
|
142
|
135
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
37
|
40
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
12
|
13
|
15
|
43
|
83
|
167
|
85
|
32
|
|
| Total Liabilities |
1
N/A
|
2
+38%
|
3
+61%
|
10
+241%
|
10
+3%
|
40
+291%
|
53
+33%
|
52
-2%
|
126
+141%
|
189
+50%
|
250
+33%
|
265
+6%
|
206
-22%
|
|
| Equity | ||||||||||||||
| Common Stock |
7
|
61
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
13
|
41
|
98
|
177
|
297
|
527
|
818
|
1 125
|
1 465
|
1 693
|
1 969
|
2 055
|
|
| Additional Paid In Capital |
0
|
2
|
144
|
414
|
431
|
475
|
867
|
1 109
|
1 587
|
1 745
|
1 822
|
1 870
|
1 957
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Equity |
3
N/A
|
50
+1 570%
|
103
+106%
|
315
+205%
|
254
-19%
|
178
-30%
|
339
+91%
|
291
-14%
|
462
+59%
|
280
-40%
|
127
-55%
|
99
N/A
|
97
+2%
|
|
| Total Liabilities & Equity |
4
N/A
|
52
+1 105%
|
106
+105%
|
325
+206%
|
264
-19%
|
218
-17%
|
392
+80%
|
343
-12%
|
588
+72%
|
468
-20%
|
376
-20%
|
166
-56%
|
109
-34%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
19
|
19
|
20
|
29
|
29
|
31
|
46
|
57
|
83
|
92
|
96
|
4
|
6
|
|
Switch to:
Switch to:
See Also
Discover More
